2015
DOI: 10.4314/ahs.v14i4.8
|View full text |Cite
|
Sign up to set email alerts
|

Resistant plasmid profile analysis of multidrug resistant <i>Escherichia coli</i> isolated from urinary tract infections in Abeokuta, Nigeria

Abstract: Background: Multi-drug resistant Escherichia coli has become a major threat and cause of many urinary tract infections (UTIs) in Abeokuta, Nigeria. Objectives: This study was carried out to determine the resistant plasmids of multidrug resistant Escherichia coli isolated from (Urinary tract infections)UTIs in Abeokuta. Methods: A total of 120 Escherichia coli isolates were obtained from urine samples collected from patients attending inpatient and outpatient clinics presenting UTI; with their biodata. Antibiot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

16
38
7

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(61 citation statements)
references
References 32 publications
16
38
7
Order By: Relevance
“…Some reports also state that this antibiotic has been facing an extensive microbial resistance across the globe. The resistance rate for this drug in the present study is greater than the result of a study in 2012 conducted at three hospitals in South West Nigeria, in which 34.5% were resistant to ceftriaxone [16]. Several studies have confirmed that Pseudomonas aeruginosa is mostly resistant against ceftriaxone [3,17,18].…”
Section: Discussioncontrasting
confidence: 54%
“…Some reports also state that this antibiotic has been facing an extensive microbial resistance across the globe. The resistance rate for this drug in the present study is greater than the result of a study in 2012 conducted at three hospitals in South West Nigeria, in which 34.5% were resistant to ceftriaxone [16]. Several studies have confirmed that Pseudomonas aeruginosa is mostly resistant against ceftriaxone [3,17,18].…”
Section: Discussioncontrasting
confidence: 54%
“…The IMP type is the most clinically significant carbapenemases which encoded by blaIMP gene and harden all treatments done using the imipenem. 31 Our results also showed that about 96.03% of imipenem-resistant P. aeruginosa strains harbored the blaIMP-1 gene which was considerable. Peymani et al (2015) 32 revealed that 107 (35.66%) P. aeruginosa isolates were non-susceptible to imipenem and/or meropenem and among them, 56 (52.3%) isolates were MBL producer.…”
Section: Discussionsupporting
confidence: 59%
“…In this study, the percentage of papC gene was 10% which is lower than the result obtained by (Rocha et al, 2008) (Olayinka et al, 2009) who reported that P. aeruginosa showed resistance to ciprofloxacin and chloramphenicol at a percentage of 90.2% and 97.8%, respectively but higher than that reported by (Akingbade et al, 2012) (Moniri and dastehgoli, 2007) who reported that E. coli showed resistance to ciprofloxacin at a percentage of 69.7% but higher than that reported by (Miles et al, 2006) who found that E. coli showed resistance to ciprofloxacin, norfloxacin and and ofloxacin at a percentage of 11.8%, 20.6% and 14.7%, respectively and this higher resistance may be due to frequent using of the same antibiotic in treatment which lead to resistance to this antibiotic but lower than that reported by (Jahantigh and Reza, 2015) who said that E. coli isolates were resistant to ciprofloxacin and norfloxacin at a percentage of 91% and 88%, respectively.…”
Section: Suspectedcontrasting
confidence: 54%